Fusion Pharm
FSPM · OTC
About FSPM
- Employees
- 2
- Headquarters
- Commerce City, Colorado
- Listed
- Jul 17, 2001
- Sector
- Consumer Staples
- Industry
- Food Products
- Website
- fusionpharminc.com
FSPM key statistics
- Market cap
- 13
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 3.99K
- Volume
- 1.00K
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $0.0002
- 52 Week low
- $0.00
Fusion Pharm (FSPM) at a glance
As of Sep 29, 2026, Fusion Pharm (FSPM) shares are priced at $0.00, giving the company a market cap of 13 and a price-to-earnings ratio of 0.00.
Volume so far is 1.00K shares, below the average of 3.99K shares a day.
Over the past year Fusion Pharm has ranged from $0.00 to $0.0002, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as Fusion Pharm
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- OLOXOlenox Industries$0.737+5.18%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- AHTAshford Hospitality Trust$1.79−2.72%
- SPCXSpace Exploration Technologies$147.79−0.11%
- NWGLCL Workshop Group$0.1522+27.90%
- NIVFNewGenIvf Group$0.2499−11.73%
- DKIDarkiris$0.0479−6.08%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.